Advances in Statistical Approaches to Oncology Drug Development

Anastasia Ivanova, Gary L. Rosner, Olga Marchenko, Tom Parke, Inna Perevozskaya, Yanping Wang

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The authors describe some recent developments in statistical methods and practice in oncology drug development from an academic and an industry perspective. Many adaptive designs were pioneered in oncology, and oncology is still at the forefront of novel methods to enable better and faster go/no-go decision making while controlling the cost.

Original languageEnglish (US)
Pages (from-to)81-89
Number of pages9
JournalTherapeutic Innovation and Regulatory Science
Issue number1
StatePublished - Jan 2014


  • MTD
  • cancer trial
  • model-based design
  • oncology drug development
  • stopping rule

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)


Dive into the research topics of 'Advances in Statistical Approaches to Oncology Drug Development'. Together they form a unique fingerprint.

Cite this